Nobilis health presentation 1.8.18

1. Private Lender PresentationNYSE American: HLTH
January 8, 2018
Corporate Presentation
1

2. This presentation contains forward-looking information (within the meaning of applicable securities laws) relating to the
business of Nobilis Health Corp. (the "Company") and the environment in which it operates. Forward-looking information
may include statements regarding the objectives, business strategies to achieve those objectives, expected financial results,
economic or market conditions, industry specific information, and the outlook of or involving the Company and its
business. Such forward looking information or statements are typically identified by words such as "believe", "anticipate",
"expect", "intend", "plan", "will", "may" and other similar expressions.
Forward-looking information, including any financial outlooks, is provided for the purpose of providing information about
management's expectations and plans about the future and may not be appropriate for other purposes. Forward-looking
information herein is based on various assumptions and expectations that the Company believes are reasonable in the
circumstances. No assurance can be given that these assumptions and expectations will prove to be correct and the
forward-looking information, including the financial outlooks included in this Presentation, should not be unduly relied
upon. Those assumptions and expectations are based on information currently available to the Company, including the
historic performance of the Company's business. Such assumptions include anticipated financial performance, current
business, industry and economic trends, and business prospects and are subject to the risks and uncertainties which are
discussed in the Company's regulatory filings available on the Company's web site at www.NobilisHealth.com, www.sec.gov,
or at www.sedar.com. Any forward-looking statements that we make are based on assumptions as of today, and we
undertake no obligation to update them.
The Company’s management has approved the financial outlooks contained in this presentation.
FORWARD-LOOKING INFORMATION
2

3. LOCATIONS
• 10 markets across 5 states
• 5 surgical hospitals
• 13 ASCs
• 13 multi-specialty clinics
• 36 partner facilities
STRATEGY
• Optimized case mix and payor mix across the portfolio
• Higher acuity procedures leading to higher levels of
reimbursements
• Focus on minimally invasive procedures
• Compelling value proposition for physicians,
patients, and payors
• Low Cap-Ex requirements
• Scalable platform enables nationwide growth
COMPANY OVERVIEW
DIRECT-TO-PATIENT MARKETING MODEL
• Branded procedures drive additional surgical volume to nation-wide
network of facilities
• Capitalizes on growing trend of ‘consumerism’ in healthcare
• Drives organic growth
$315 million in revenue & $40 million in Adjusted EBITDA, LTM September 2017
Markets with Nobilis owned facilities
Markets with Nobilis partner facilities
3

4. UNIQUE MARKETING MODEL
• Multiple marketing channels drive organic volume growth
• Proprietary technology platform targets prospective patients
• Strong value proposition: Superior patient experience that expands physicians’ practices
ATTRACTIVE FINANCIAL PROFILE
PATIENT-CENTRIC VALUE PROPOSITION
FAVORABLE PAYOR AND PROCEDURE MIX
ATTRACTIVE INDUSTRY FUNDAMENTALS
EXPERIENCED MANAGEMENT TEAM
• Low leverage
• Low capital expenditure requirements
• Stable cash balance
• Unique marketing model increases case volume and provides superior patient experience
• Offers optimal surgical environments that result in better overall quality of care
• Offers ancillary services that lead to better efficiency and outcomes
• Marketing segment targets higher acuity cases resulting in a highly attractive case mix
• Procedure diversification increases the stability of the revenue base
• Minimal government payor claims reduces risk of Medicare/Medicaid rate changes
• 66% of all surgeries are outpatient with >50% performed in ASCs vs. 32% in 2005
• Lower cost, high quality outpatient setting; trend toward increased consumerism in healthcare
• Abundance of desirable acquisition opportunities due to fragmented market
• Strong management team with M&A and healthcare experience
• Seasoned Ops team leads to financial and operational efficiencies
• Strong in-house and outside legal team to safely navigate complex healthcare space
INVESTMENT HIGHLIGHTS
4

5. UNIQUE PATIENT ACQUISITION MODEL
• Acquires patients from physician partners who are not
obligated to bring cases to their facility
• Physicians often form partnerships with inequitable
percentages:
• Productive doctors resent less productive doctors
• Management Co. only manages and does not drive patients
to centers
• No growth drivers – must rely on physician partners to grow
their practices to then bring more patients
• No vertical integration
Traditional Model The Nobilis Model
• Acquire patients through:
• Marketing programs
• Network of primary care
physician partners
• Physician employees
• Ownership is just one of several
alignment opportunities between
physicians and Nobilis
• Nobilis owns and manages its facilities
Nobilis Health
Network / Clinically
Integrated Network
Physician
Partners
Direct to Consumer
Marketing
Joint Marketing
with Physicians
Nobilis Health
Employed Primary
Care Physicians
• Drive patient flow to our facilities
• Control the patient experience through an
expanding continuum of care:
• Patient acquisition
• Primary care
• Ancillaries
• Surgeries
• Post-Op
Physician
Partners
(Minority Ownership)
5

6. FAVORABLE CASE MIX FAVORABLE PAYOR MIX
Note: Unless otherwise dated, figures are based on the LTM period ended 9/30/2017, pro forma for the full year impact of the AZ Vein acquisition.
Note 2: Case mix based on number of cases; payor mix based on revenue.
ENT
4%
General Surgery
4%
Ortho
7%
Pain
26%
Spine
18%
Bariatrics
19%
Vein/Vascular
4%
Podiatrist
2%
GI
1%
Plastic
Surgery
10%
GYN
3%
Migraine
2%
AETNA
22%
BCBS
16%
CIGNA
9%
UHC
33%
Other
Commercial
10%
Self Pay
6%
WC
3%
Medicare
1%
NOBILIS BUSINESS OVERVIEW
6
“Targeting Higher Acuity Cases” “Minimal Government Payor Claims”

7. Private Lender Presentation
INDUSTRY OVERVIEW
7

8. AMBULATORY SURGICAL CENTERS (ASCs)
• Outpatient only
• > 5,500 ASCs nation-wide
• 70%+ owned by independent
physician groups
• Full-service hospital
• Inpatient and outpatient
• > 5,700 hospitals nation-wide
• 60%+ not-for-profit
SPECIALTY SURGICAL HOSPITALS (SSHs)
• Typically outpatient focused
• Inpatient and outpatient
• ~300 SSHs nation-wide
SURGICAL SETTING BACKGROUND
TRADITIONAL HOSPITALS
NOBILIS HEALTH
8

9. INDUSTRY GROWTH
• Efficient cost structures
• Increased government focus on healthcare
• Aging population
• Newly insured access care
• Economies of scale drive partnership decision
for physician-owned facilities
• > 50% of outpatient surgeries performed in
ASC setting vs. 32% in 2005
GROWTH OF THE ASC INDUSTRY
PROJECTED ASC INDUSTRY REVENUE
Independent operators, hospitals, & small chains comprised 78% of ASCs in the U.S.
($ in billions)
$16 $17
$19 $20 $21 $22 $23
$25
$27
$30
$32
$34 $36
$38
$40
$0
$5
$10
$15
$20
$25
$30
$35
$40
$45
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015E
2016E
2017E
2018E
2019E
2020E
Source: CSM, Equity Research, IBIS healthcare expenditures estimates, Becker’s.
9

10. THE SPINE SHIFT
• Less complex spine procedures shifting from inpatient to outpatient
• Key spine procedures have stronger tailwinds due to demographics and improvements in technology
• ~31 million Americans suffer from chronic back pain
• ~600,000 Americans undergo spine surgery every year
INPATIENT SPINE DISCHARGES 2014 - 2019
SHIFT TO OUTPATIENT
OUTPATIENT SPINE DISCHARGES 2014 - 2019
Note: Growth rate data reflects U.S. market.
Source: Wall Street Research.
Advanced Imaging 13%
Arthrocentesis / Injections
5%
Rehab & Chiropractic
14%
Standard Imaging
13%
E&MVisits
17%
Fusion Surgery
Spinal Decom. / Laminec.
Vertebral Augmentation
23%
27%
25%17%
-9%
-5%
-2%
2%
-11%
Nobilis Key
Procedures
Lumbar / Thoracic Fusion
Cervical Fusion
No Procedure and
Diagnostics
Spinal Decompression/
Laminectomy
Vertebral Augmentation
Procedures
Revision Spinal Procedure
10

11. Private Lender Presentation
GROWTH STRATEGY
11

12. MARKETING EXPERTISE DRIVES ORGANIC GROWTH
• Multiple marketing channels drive volume growth
at hospitals, ASCs, and ancillary service lines
• Bundled payment capabilities
• Strategically adding new marketing brands to portfolio
• Branded referral program, 360 Concierge
SERVICE LINES AND SPECIALTIES
• Continue optimizing case mix to maximize revenue
potential
• Increase the volume of high acuity procedures that
benefit from higher levels of reimbursement
• Identify and develop additional service lines
appropriate for outpatient environment
GROWTH STRATEGY
ACQUISITION OPPORTUNITIES
• Highly fragmented market with many ideal acquisition targets
• Focus on targets that allow Nobilis Health to cross-sell
service lines and leverage marketing capabilities
• Pursuing in-network targets that are amenable to Nobilis Health
marketing platform and allow the Company to leverage
existing infrastructure
• Acquisition strategy includes facilities and clinical practices
1
3
2
4 OPERATIONAL LEVERAGE
• Focus on driving cost reductions throughout system
• Identify and achieve greater economies of scale as Nobilis
continues acquiring new businesses and expanding
its platform
• Experienced leadership team with decades of healthcare
experience
• Clinically integrated network for contracting and care
coordination
12

13. DIRECT-TO-CONSUMER MARKETING
• Marketing and technology platform targets
prospective patients
• Unique value proposition to physicians; superior patient
experience
• Scalable revenue driver
• Portfolio effect – direct cases to specific facilities on a
procedure-by-procedure basis for best clinical outcome
and return on investment
UNIQUE PATIENT ACQUISITION STRATEGY
PHYSICIAN SALES
• In-house marketing team
• Builds and executes marketing plans on behalf of physicians
• Expands physicians’ practices, optimized payor and procedure
mix, and drives additional volume to Nobilis facilities
• High average return-on-investment (ROI)
13

14. HIGH TOUCH MARKETING MODEL
Lead Generation
Direct-to-Patient Engagement Points
• Digital
• Traditional (TV, Radio)
• Email & Content
• Real-Time Fulfillment
Concierge Service
Inside Sales Team + IT Platform
• Dedicated Patient Coordinators
• Multi-touch, Full Service Process
• Proprietary Software Solutions
• CRM
Conversion to Surgical Patient
Patient Process Management
• Patient Education
• Imaging Review by Medical Team
• Insurance Verification & Explanation
• Surgery Clearance Management
• Surgery Scheduling/Coordination
Patient Tracking
Patient Experience Follow Up/Facilitate Research
• Post Operative Follow-up Contact
• Patient Experience Surveys & Testimonial
• Referral Request
• 360 Concierge Tracking Through-out Continuum
of Care
• Promotes Succinct Treatment Algorithm which
Results in Improved Patient Outcomes and Lower
Healthcare Costs
14

15. FIRST ASSIST
• Cover 100% of outpatient spine cases through
qualifying direct-to-consumer
• Specialties: spine, bariatrics, ENT, orthopedic, plastic,
and general surgery
NEUROMONITORING
• Focused on spine procedures (100% of
direct-to-consumer cases)
• 5 states with 54 different facilities (Nobilis & Non-Nobilis)
• Specialties: spine, neuro, orthopedic, CV, and ENT
ANCILLARY SERVICES
ANESTHESIA
• All Nobilis facilities
• Helps recruit partner physicians
• Specialties: spine, bariatrics, ENT, orthopedic, plastic, and
general
PHYSICAL THERAPY
• Launched April 2017 as a hospital outpatient department
of Plano Surgical Hospital
• Provides patients and physicians with a partner in the
continuum of care
15

16. BENEFITS
• Continuity of care for patients
• Helps recruit top physicians
• Increases patient and physician satisfaction
• Improves patient outcomes
• Accretive to earnings
ANCILLARY SERVICES
DEVELOPMENT
• Nobilis actively seeks potential M&A targets in the
ancillary services space
• Focus on acquisitions with revenue potential system
wide
• Increased capabilities position Nobilis to execute
alternative payment methodologies for payors
PATIENT CENTRIC STRATEGY
• Achieve economies of scale
• Make efficient use of capital and operating resources
• Treat same level of demand with less capacity then
stand alone facilities
• Results in increased productivity, lower staffing
requirements and reduced operating and unit costs
FINANCIAL CONTRIBUTION
• 2016 revenue of $20.4 million compared to $2.3
million in 2015
• Maximizes revenue by capturing additional revenue
streams per patient
16

17. • Concertis is Nobilis Health’s Clinically Integrated Network (CIN) of
healthcare providers, ancillary providers, and facilities that
improves the patient experience across the continuum of care
• The CIN captures referrals from primary care physicians to
coordinate patient care with Nobilis Health ancillary providers, surgeons
and facilities
• 360 Concierge and the physician portal, divisions of Concertis,
allow providers the ability to monitor patient care as they move
through the Nobilis Health continuum of care
• As of September, we have over 100 providers in the 360 Concierge
system across our three major markets, which has resulted in over 1,000
referrals to the Nobilis Health system
• Align with physicians through employment, bundled payment
products, 360 Concierge, and other financial and clinical products
CONCERTIS STRATEGY
PRIMARY CARE PRACTICES
• Less expensive to acquire than specialists
• Allows Nobilis Health to control patient experience across the
continuum of care
• Feeds volume into bundled payment and 360 Concierge
• Achieves clinical integration
• Bring physicians into our narrow network
• Our care navigators are trained health care professionals who
serve as patient concierges, guiding patients through the
entire episode of care from diagnosis to post-surgical care
17

18. Private Lender Presentation
ELITE TRANSACTION OVERVIEW
18

19. • 4 ASCs & Surgical Hospitals in Houston Metro Area
• $49.0M LTM 9/30/17 Revenue
• $30.3M LTM 9/30/17 Adjusted EBITDA
• 76 Physician Partners
• 86 Referring Physicians
COMBINED REGIONAL LEADER
This image cannot currently
be displayed.
• 14 ASCs & Surgical Hospitals
• 5 ASCs & Surgical Hospitals in Houston Metro Area
• $314.8M LTM 9/30/17 Revenue (1)
• $39.6M LTM 9/30/17 Adjusted EBITDA (1)
• 41 Physician Partners
• 490 Referring Physicians
(1) Pro forma for the full year impact of the AZ Vein acquisition.
(2) Includes $2 million of estimated cost synergies resulting from the consolidation of one Elite and one Nobilis ASC currently colocated at the same address.
ASCs &
Surgical Hospitals
ASCs, Surgical
Hospitals & Clinics in
Houston Metro
LTM 9/30/17
Revenue
LTM 9/30/17
Adjusted EBITDA
(Net NCI)
Physician
Partners
Referring
Physicians
19

20. CASE MIX
PAYOR MIX
19,325
29,126
30,978 30,701
0
5,000
10,000
15,000
20,000
25,000
30,000
35,000
2014 2015 2016 LTM
6/30/17
Cases
CASE VOLUME & REVENUE PER CASE
IN-NETWORK CASE MIX
Pain
27%
Spine
15%
Ortho
14%
Bariatrics
14%
ENT
9%
Plastic
7%
Podiatrist
4%
Other
11%
UHC 29%
Aetna 23%
BCBS TX
12%
BCBS 6%
Other
Commercial
12%
Cigna 11%
Self
4%
Worker's Comp 2%
Medicare 0.6%
Out-of-
Network
54%
In-Network
46%
$7,380
$9,634
$11,432
$12,344
$0
$2,000
$4,000
$6,000
$8,000
$10,000
$12,000
$14,000
2014 2015 2016 LTM
6/30/17
Rev. Per Case
PRO FORMA POST ACQUISTION
Note: All figures unless otherwise stated are based on LTM 6/30/2017 pro forma for the full year impact of the AZ Vein acquisition.
20

21. Private Lender Presentation
FINANCIAL OVERVIEW
21

22. REVENUE AND ADJUSTED EBITDA
FINANCIAL PERFORMANCE
(Millions)
$31
$84
$229
$286
$310 - $325
$3
$11
$40
$34
$40 - $45
$-
$20
$40
$60
$80
$100
$120
$140
$-
$50
$100
$150
$200
$250
$300
$350
2013 2014 2015 2016 2017E
Total Revenue Adj. EBITDA
Track Record of Strong Revenue and
Adj. EBITDA Growth
22
*Lower end of guidance due to impact of Hurricane Harvey.
2017 Guidance provided on March 13, 2017:
Revenue: $310M-$325M
Adj. EBITDA: $40M-$45M
Revenue
Adj. EBITDA

23. TOTAL REVENUE
$51
$68
$62
$80
$71 $65
$286
$310 - $325
$0
$50
$100
$150
$200
$250
$300
$350
Q1 16 Q1 17 Q2 16 Q2 17 Q3 16 Q3 17 2016 2017E
Revenue
2017 OPERATING PERFORMANCE
23
*Lower end of guidance due to impact of Hurricane Harvey.
2017 Guidance provided on March 13, 2017:
Revenue: $310M-$325M
Adj. EBITDA: $40M-$45M
(Millions)

24. ADJUSTED EBITDA
$0.4
$2
$9
$10
$4
$7
$34
$40 - $45
$0
$10
$20
$30
$40
$50
Q1 16 Q1 17 Q2 16 Q2 17 Q3 16 Q3 17 2016 2017E
Adj. EBITDA
2017 OPERATING PERFORMANCE
24
*Lower end of guidance due to impact of Hurricane Harvey.
2017 Guidance provided on March 13, 2017:
Revenue: $310M-$325M
Adj. EBITDA: $40M-$45M
(Millions)

25. ORGANIC vs. ACQUISITION GROWTH
25
(Millions)
YEAR-OVER-YEAR ORGANIC GROWTH
$0
$50
$100
$150
$200
$250
$300
$350
2013 2014 2015 2016
Revenue
Total Organic Revenue Total Acquired Revenue
Total Rev: $84mm
YoY Growth: $53mm
Total Rev: $229mm
YoY Growth: $146mm
Total Rev: $286mm
YoY Growth: $57mm
Total Rev: $31mm
YoY Growth: $10mm

26. 26
KEY METRICS
Total cash of $34.1 million at September 30, 2017, compared with $24.6 million at December 31, 2016
STOCK SNAPSHOT (01/05/18) FINANCIAL SNAPSHOT (9/30/2017)
*All amounts in millions, unless denoted otherwise
*Source: Yahoo Finance
Symbol (NYSE American) HLTH
Share Price $1.35
Market Cap $105
Shares Outstanding 77.8
Float 56
Insider Ownership (%) 28
LTM Adjusted EBITDA $39.6
EV/EBITDA 4.3x
Price/ Sales (LTM) 0.33x
Cash $34.1
Accounts Receivable $112.4
Net Income $1.0
Fully Diluted EPS $0.01
Projected CAPEX $7 - $8
Total Debt $75.7
Net Debt $41.6
Leverage Ratio 1.9x

27. 27
FINANCIAL STATEMENT HIGHLIGHTS
INCOME STATEMENT
STATEMENT OF CASH FLOWS
BALANCE SHEET
As of 9/30/2017
(Millions)
Cash $34.1
Total Assets $317.1
Total Debt $75.7
Total Liabilities $159.1
Net Cash Provided by Operating Activities $27.9
Net Cash Used For Investing Activities $(13.3)
Net Cash Used For Financing Activities $(5.0)
Total Revenue $64.7
Operating Expenses
Salaries and Benefits
Drugs and Supplies
General and Administrative
Depreciation and Amortization
Total Operating Expenses
Corporate Expenses
Salaries and Benefits
General and Administrative
Legal
Depreciation
Total Corporate Expenses
$15.7
$10.4
$27.6
$2.7
$56.4
$2.9
$3.3
$0.7
$0.1
$7.0
Net Income $1.0
Adjusted EBITDA $6.7

28. Private Lender Presentation
APPENDIX
28

29. HARRY FLEMING
Chief Executive Officer & Chairman of the Board
• Joined Nobilis in 2010
• Previously served as CFO, President and Executive Chairman of Nobilis
• Earned an MBA from Boston College, a J.D. from the University of Houston, and a B.A. from the
University of St. Thomas
• Joined Nobilis in 2010
• Previously served as Chief Operating Officer & Chief Business Development Officer at Nobilis
• Founder & CEO of Diagnostic and Interventional Spine Centers
• Doctorate from Texas Chiropractic College
• Joined Nobilis in 2017
• Previously served as Divisional CFO for St. Jude Medical’s America division
• Licensed CPA
• Earned an MBA from the University of Texas at Austin
• Joined Nobilis in 2014
• 15 years of healthcare sales and business development
• Previously held successful sales leadership positions at Intuitive Surgical, Medtronic, and Pfizer
• Earned a B.A. from Rhodes College
• Joined Nobilis in 2016
• Partner at Baker Donelson, specializing in health law and served as a Director of Legal Services
at Houston Methodist Hospital System
• Earned a J.D. from the University of Houston and B.A. cum laude from Rice University
MANAGEMENT TEAM
KENNETH EFIRD
President
DAVID YOUNG
Chief Financial Officer
PATRICK YODER
Chief Revenue Officer
MARISSA ARREOLA
Chief Strategy Officer / President, Concertis
29

30. MARCOS RODRIGUEZ
Chief Accounting Officer
• Joined Nobilis in 2016
• Began his career at Deloitte & Touche LLP and served five years as Director at Opportune LLP
• 19 years of financial & accounting reporting, external and internal audits, and SEC regulations
• Earned a B.S. from Louisiana State University and is a licensed CPA
• Joined Nobilis in 2017
• 20 years of operational and managerial experience in the healthcare industry
• VP of Continuous Improvement for United Surgical Partners International/ Tenet Healthcare
(“USPI”) and CEO of Memorial Hermann Surgical Hospital Kingwood, in Houston, Texas
• M.S. in Healthcare Management-Emergency Services from University of Maryland
• Joined Nobilis in 2015
• Previously served as CFO at Northstar Healthcare LLC and Nobilis Health
• 20 years of financial and accounting reporting in the healthcare industry
• Earned an M.B.A. from Texas Woman’s University and a B.S. from Sacred Heart University
• Joined Nobilis in 2017
• Previously served as Director of Marketing for Travelocity and Director of Online Marketing at
Hotels.com
• Earned a J.D. from University of Tennessee College of Law and a B.S. from Vanderbilt University
• Joined Nobilis in 2014
• 10 years of finance & accounting experience in the healthcare industry, including HCA & Tenet
• Earned an M.B.A. from University of Texas – San Antonio and a B.S. from New York University
MANAGEMENT TEAM
MARC CELIA
EVP of Operations
KENNETH KLEIN
CFO of Operations
PHIL AYRES
VP of Marketing
BRANDON MORENO
VP of Finance
30

31. TEXAS (DALLAS AND HOUSTON) EQUITY
First Nobilis Hospital -------------------------------------------------------------------------- 51%
Hermann Drive Surgical Hospital ---------------------------------------------------------- 54.75%
Plano Surgical Hospital ----------------------------------------------------------------------- 100%
Hospital for Surgical Excellence of Oak Bend-------------------------------------------- 50.1%
ARIZONA (SCOTTSDALE)
Scottsdale Liberty Hospital ------------------------------------------------------------------ 75%
NOBILIS FACILITIES
Hospitals
31

32. TEXAS (DALLAS, HOUSTON, AND EL PASO) EQUITY
First Nobilis Surgical Center (HOPD) ------------------------------------------------------ 51%
Kirby Surgical Center -------------------------------------------------------------------------- 25%
Medical Park Drive Specialty Center (HOPD) -------------------------------------------- 51%
Elite Center for Minimally Invasive Surgery (HOPD) ------------------------------------ 50.1%
Houston Metro Ortho & Spine Surgery Center (HOPD) ------------------------------- 50.1%
Elite Sinus Spine & Ortho (HOPD) ---------------------------------------------------------- 50.1%
Mountain West Surgery Center (HOPD) ------------------------------------------------ 100%
Uptown Surgery Center (HOPD) ---------------------------------------------------------- 100%
ARIZONA (PHOENIX, SCOTTSDALE, AND TUCSON)
Northstar Healthcare Surgery Center – Scottsdale -------------------------------------- 100%
Chandler Surgery Center ---------------------------------------------------------------------- 100%
Oracle Surgery Center -------------------------------------------------------------------------- 100%
Phoenix Surgery Center ------------------------------------------------------------------------ 100%
Surprise Surgery Center ------------------------------------------------------------------------ 100%
NOBILIS FACILITIES
ASCs
32

33. TEXAS (DALLAS, HOUSTON, ROUND ROCK, SAN ANTONIO) EQUITY
Hamilton Vein Sugar Land Clinic ------------------------------------------------------------- 100%
Hamilton Vein Woodlands Clinic ------------------------------------------------------------ 100%
Hamilton Vein Clear Lake Clinic -------------------------------------------------------------- 100%
Hamilton Vein Katy Clinic ---------------------------------------------------------------------- 100%
Hamilton Vein Stone Oak Clinic --------------------------------------------------------------- 100%
Hamilton Vein Round Rock Clinic ------------------------------------------------------------- 100%
ARIZONA (CHANDLER, GLENDALE, PHOENIX, SCOTTSDALE, AND TUCSON)
Arizona Vein & Vascular Chandler Clinic ---------------------------------------------------- 100%
Arizona Vein & Vascular Oracle Clinic ------------------------------------------------------- 100%
Arizona Vein & Vascular Phoenix Clinic ----------------------------------------------------- 100%
Arizona Vein & Vascular Surprise Clinic ---------------------------------------------------- 100%
DeRosa Medical Clinic – Glendale ----------------------------------------------------------- 100%
DeRosa Medical Clinic – Chandler ----------------------------------------------------------- 100%
DeRosa Medical Clinic – Scottsdale ---------------------------------------------------------- 100%
NOBILIS FACILITIES
Clinics
33

34. NOBILIS FACILITIES
34
FACILITY NAME FACILITY DETAILS SPECIALTIES
PLANO SURGICAL HOSPITAL • 26 Inpatient Beds • Bariatrics
• 6 ORs • Spine
• 2 Procedure Rooms • Plastic Surgery
• Orthopedics
• General Surgery
• Pain Management
KIRBY SURGICAL CENTER • 4 ORs • Orthopedics
• 1 Procedure Room • General Surgery
• Pain
• ENT
HERMANN DRIVE SURGICAL HOSPITAL • 22 Beds • Bariatrics
• 18 Private Rooms • Spine
• 6 ORs • Plastic Surgery
• 2 Procedure Rooms • Orthopedics
• General Surgery
FIRST STREET SURGICAL HOSPITAL • 4 ORs • Bariatrics
• 1 Procedure Room • Spine
HOPDs of First Surgical Hospital: • Plastic Surgery
First Street Surgery Center • 4 ORs • Orthopedics
Medical Park Specialty Center • 1 OR • General Surgery
• Pain Management
ATRIUM MEDICAL CENTER • Bariatrics
• Spine
HOPDs of Atrium Medical Centre: • Plastic Surgery
Uptown Surgery Center • 2 ORs • Orthopedics
• General Surgery
• Pain Management

35. NOBILIS FACILITIES
35
FACILITY NAME FACILITY DETAILS SPECIALTIES
NORTHSTAR HEALTHCARE SURGERY CENTER - SCOTTSDALE • 4 ORs • Plastic Surgery
• 1 Procedure Room • Orthopedics
• General Surgery
• Pain management
• Bariatrics
• Podiatry
SCOTTSDALE LIBERTY HOSPITAL • 12 Inpatient Beds • Spine
• 2 ORs • Orthopedic Surgery
• 1 Procedure Room • General Surgery
• Podiatry
• Bariatrics
• Migraine
• Vascular
ARIZONA VEIN & VASCULAR CENTER • 4 Clinics • Vascular
• 4 ASCs
• 15 ORs
HAMILTON VEIN CENTER • 6 Clinics • Vascular
• 20 Radiofrequency Ablations (RFAs)
DEROSA MEDICAL • 3 Clinics • Health & Wellness
• 9 Providers • Weight Loss
• Chronic Health Condition Management
MESA HILLS SPECIALTY HOSPITAL
HOPDs of Mesa Hills Specialty Hospital:
Mountain West Surgery Center • 2 ORs
• 2 Procedure Rooms
• Spine
• Orthopedic Surgery
• General Surgery
• Podiatry
• Bariatrics
• Migraine
• Plastic Surgery

36. NOBILIS FACILITIES
36
FACILITY NAME FACILITY DETAILS SPECIALTIES
ELITE CENTER FOR MINIMALLY INVASIVE SURGERY (“TRAVIS”) • 4 ORs • Orthopedic
• 2 Treatment Rooms • ENT
• 1 Private Rooms - Overnight • Pain
• Podiatry
• GI
HOUSTON METRO ORTHO & SPINE SURGERY CENTER (“METRO”) • 3 ORs • ENT
• 2 Treatment Rooms • Orthopedic
• 2 Private Rooms - Overnight • Pain
• Spine
ELITE SPINE SINUS & ORTHO (“RIVER OAKS”) • 22 Beds • Pain
• 18 Private rooms • Orthopedic
• 6 ORs • Podiatry
• 2 Procedure Rooms • Oculoplastic
• Plastic Surgery
• Ophthalmology
• Spine
• ENT
HOSPITAL FOR SURGICAL EXCELLENCE OF OAK BEND • 4 ORs • Pain
• 1 Treatment Room • Orthopedic
• 6 Inpatient Rooms • Podiatry
• GI
• Spine
• ENT
• Urology

37. NOBILIS BRANDS
North American Spine
The flagship brand, North American Spine
offers innovative, minimally invasive back and
neck surgeries and enjoys a solid track record of
superior outcomes. The minimally invasive,
laser spine procedures enjoy high recognition in
their markets and the aging population
encourages strong natural growth.
Clarity Vein & Vascular
Clarity Vein and Vascular provides minimally
invasive surgical treatment of painful and/or
unsightly vascular conditions ranging from the
relatively benign, like varicose or spider veins,
to the dangerous, like deep vein thrombosis or
peripheral artery disease.
Hamilton Vein Center
Hamilton Vein and Vascular is a full-service
clinical practice with multiple Texas locations
and an impressive record of successful
treatments. Adept at cosmetic procedures for
conditions like spider and varicose veins, the
practice also excels at diagnosing and treating
potentially harmful underlying conditions.
Migraine Treatment Centers of America
Migraine Treatment Centers of America is the
exclusive provider of the Omega™ Procedure, a
non-pharmaceutical surgical implant for the
relief of chronic migraine pain. Increasing
awareness of neurostimulation techniques,
vocal support from past patients, and favorable
insurance policies position the brand as very
high growth.
Arizona Vein & Vascular Center
Arizona Vein and Vascular is a mature practice
in the Phoenix/Scottsdale area that, like Clarity
Vein and Vascular, provides minimally invasive
treatment of venous conditions and disorders
from the unsightly to the dangerous.
MIRI Women’s Health
MIRI Women’s Health focuses on minimally
invasive surgeries for gynecological conditions
and offers second opinions for those seeking an
alternative to traditional hysterectomies.
Evolve
Evolve, a bariatric surgery brand, benefits from
increasing medical consensus on the health
benefits of bariatric surgery over conventional
diet and exercise for the significantly or morbidly
obese. Nationally rising rates of obesity and more
farsighted, preventive insurance policies poise
the brand for strong growth.
Onward Orthopedics
Onward Orthopedics treats non-spine joint
issues for patients of all ages and types. The
brand benefits from partner physicians with
solid histories of high-profile sports clients, and
can provide referrals to the North American
Spine and NueStep brands.
NueStep
NueStep focuses on the minimally invasive
relief of foot and ankle pain due to nerve
entrapment and a variety of other podiatric
issues. The brand’s success is a result of
educational marketing campaigns designed to
correct a historical under-appreciation of foot
pain and therapeutic modes used to address it.
37

38. Personalized treatment & access to multi-disciplinary medical staff & physicians
Goal: Self-source business and maximize ROI
Sales & Marketing
1
Direct to Consumer
(DTC)
Lead Generation
ConciergeService
Conversion to Surgical
Patient
Patient Experience
Follow Up
Successful Patient Outcomes
Sales Outreach to
Referral Community
Physician Referral to
Nobilis Brand
Leverage concierge
service for enhanced
patient experience
3
360 Concierge
Sales Outreach
to Physicians
Physician & Patient
Conversion
Nobilis Facility
CaseAcquisition
2
Physician
Recruitment
Patient and Physician
Satisfaction
SALES AND MARKETING STRATEGY
Our Unique
Approach
38

39. Private Lender Presentation
NYSE American: HLTH
39